Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 29 (1), 127-48, viii

Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial

Affiliations

Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial

Stanley N Caroff et al. Neurol Clin.

Abstract

Drug-induced movement disorders have dramatically declined with the widespread use of second-generation antipsychotics, but remain important in clinical practice and for understanding antipsychotic pharmacology. The diagnosis and management of dystonia, parkinsonism, akathisia, catatonia, neuroleptic malignant syndrome, and tardive dyskinesia are reviewed in relation to the decreased liability of the second-generation antipsychotics contrasted with evidence from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial. Data from the CATIE trial imply that advantages of second-generation antipsychotics in significantly reducing extrapyramidal side effects compared with haloperidol may be diminished when compared with modest doses of lower-potency first-generation drugs.

Figures

Figure 1
Figure 1
Proposed treatment algorithm for tardive dyskinesia.

Similar articles

See all similar articles

Cited by 31 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Substances

Feedback